Family CFO’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-150
Closed -$31K 65
2025
Q4
$31K Buy
+150
New +$29.7K 0.01% 63
2025
Q3
Sell
-150
Closed -$22.9K 60
2025
Q2
$22.9K Hold
150
0.01% 65
2025
Q1
$24.9K Hold
150
0.01% 56
2024
Q4
$21.7K Hold
150
0.01% 58
2024
Q3
$24.3K Hold
150
0.01% 59
2024
Q2
$21.9K Hold
150
0.01% 51
2024
Q1
$23.7K Hold
150
0.01% 51
2023
Q4
$23.5K Hold
150
0.02% 52
2023
Q3
$23.4K Hold
150
0.02% 53
2023
Q2
$24.8K Hold
150
0.02% 47
2023
Q1
$23.3K Hold
150
0.02% 45
2022
Q4
$26.5K Hold
150
0.02% 44
2022
Q3
$24.5K Hold
150
0.03% 43
2022
Q2
$26.6K Hold
150
0.03% 43
2022
Q1
$27K Hold
150
0.03% 44
2021
Q4
$26K Buy
+150
New +$24.6K 0.03% 43

Other funds holding JNJ

Family CFO's JNJ Position: Q1 2026 in Review

Family CFO sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 150 shares — an estimated $31K sold.

Family CFO first reported a position in JNJ in Q4 2021 and held it in 16 quarters. The position peaked at $31K in Q4 2025. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Family CFO reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Family CFO sold 150 Johnson & Johnson shares in Q1 2026, an estimated $31K.
  • Family CFO first reported a position in Johnson & Johnson in Q4 2021 and held it in 16 quarters.
  • Family CFO's Johnson & Johnson position peaked at $31K in Q4 2025.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Family CFO's 13F filing for Q1 2026, filed 28 Apr 2026.